表紙:血管イメージングの世界市場(2022年~2029年)
市場調査レポート
商品コード
1065212

血管イメージングの世界市場(2022年~2029年)

Global Vascular Imaging Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 190 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
血管イメージングの世界市場(2022年~2029年)
出版日: 2022年05月07日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 約2営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の血管イメージング市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界の血管イメージング市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の血管イメージング市場-市場の定義と概要

第3章 世界の血管イメージング市場-エグゼクティブサマリー

  • 市場の内訳:タイプ別
  • 市場の内訳:アプリケーション別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界の血管イメージング市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の血管イメージング市場-業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 世界の血管イメージング市場-COVID-19分析

  • 市場のCOVID-19分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の血管イメージング市場:タイプ別

  • イントロダクション
  • 市場規模分析、および前年比成長分析(%):タイプ別
  • 市場魅力指数:タイプ別
    • 非侵襲
    • 低侵襲

第8章 世界の血管イメージング市場:アプリケーション別

  • イントロダクション
  • 市場規模分析、および前年比成長分析(%):アプリケーション別
  • 市場魅力指数:アプリケーション別
    • 診断*
    • 治療

第9章 世界の血管イメージング市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 病院*
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年)
    • 画像診断センター
    • その他

第10章 世界の血管イメージング市場:地域別

  • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2021年~2029年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第11章 世界の血管イメージング市場-競合情勢

  • 主な開発と戦略
  • 企業シェア分析
  • 製品のベンチマーク

第12章 世界の血管イメージング市場-企業プロファイル概要

  • GE Healthcare*
  • Abbott Laboratories
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Hitachi Medical Corporation
  • Samsung Medison
  • Shimadzu Medical Systems
  • Hologic Inc.
  • Fujifilm SonoSite
  • CorVascular Diagnostics

第13章 世界の血管イメージング市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMI4858

Market Overview

The global vascular imaging market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Vascular imaging is used to assess blood vessels and diagnose conditions caused by abnormal blood flow. Vascular ultrasound, computed tomography (CT), and magnetic resonance imaging are all methods for creating images of blood vessels (MRI).

Market Dynamics

The factors influencing the global vascular imaging market are the increasing demand for vascular imaging and technological advancements.

The increasing demand for vascular imaging is expected to drive market growth in the forecast period

Vascular studies measure the amount of blood flow in blood vessels using high-frequency sound waves (ultrasound). The skin is probed with a small handheld probe (transducer). Sound waves travel through the skin and other body tissues to reach blood vessels. The sound waves reverberate off the blood cells. These echoes are then sent to a computer and displayed as images or video on a screen. Vascular imaging can be used to help diagnose a variety of blood flow-related conditions, such as atherosclerosis, aneurysms, inflammatory conditions, varicose veins, and blood clots. There are two types of vascular imaging invasive and non-invasive. For instance, noninvasive vascular imaging allows physicians to use imaging technology to diagnose and assess diseases and conditions in the blood vessels. Noninvasive vascular imaging allows the doctor to see inside blood vessels, evaluate blood flow, and pinpoint areas where blood circulation is slowed or stopped. The procedures are noninvasive because they employ equipment that takes photographs from the outer body. Vascular ultrasound is a noninvasive technique (also known as a duplex study) used to examine the arms and legs of blood circulation.

Limitations associated with vascular imaging is expected to hamper the market growth

Deep vessels in the body are more difficult to see than superficial vessels. Specialized equipment or other tests such as CT or MRI may be required to visualize them properly. Smaller vessels are difficult to image and assess than larger ones. Calcifications caused by atherosclerosis may obstruct the ultrasound beam. The test is specialized and should only be performed by a vascular ultrasound imaging technologist and physician. Despite its advantages, vascular ultrasound has some limitations. Smaller and deeper vessels with vascular ultrasound can be more difficult to evaluate and image. Ultrasound cannot distinguish between an occluded blood vessel and one significantly narrowed in some cases. Calcifications may also obstruct the ultrasound beam. Other imaging tests, such as Magnetic Resonance Angiography (MRA) or CT Angiogram, may be required in these cases.

COVID-19 Impact Analysis

The pandemic coronavirus 2019 (COVID-19) significantly impacted all imaging practices across the country. Independent of COVID-19, policy measures enacted to slow disease transmission are lowering demand for imaging. Hospital preparations to increase crisis capacity further reduce the amount of appropriate medical imaging performed safely. Although economic recessions generally result in lower healthcare expenditures, imaging groups have never experienced an economic shock exacerbated by the need to limit imaging availability. These changes will greatly impact outpatient practices, but imaging volumes will decrease. According to studies, radiology practices should expect 50-70% decreases in imaging volume that will last at least 3-4 months, depending on the location of practice and the severity of the COVID-19 pandemic in each region. Hence, due to the impact of covid-19, the global vascular imaging market impacted negatively.

Segment Analysis

Based on type, the non-invasive segment is expected to dominate the market growth

A common imaging exam is non-invasive vascular imaging. It enables a doctor to assess the condition of blood vessels from the outside of the body. This entails employing several technologies, such as CT, MRI, ultrasound, vascular ultrasound. A contrast dye may be administered via a traditional IV (intravenous) line for CT and MRI exams. No catheters or other devices are inserted into the body because these studies are 'non-invasive.' These exams are performed in one of the hospital's radiology departments or a lab. A technologist typically performs the exam, and the results are interpreted and shared with a doctor by a radiologist. These minimally invasive imaging techniques are painless and relatively safe may eliminate the need for catheter-directed invasive procedures, allowing patients to leave the hospital immediately after the scan is completed.

Non-invasive vascular tests come in various forms, including a carotid ultrasound that measures arterial blood flow to the brain via the carotid arteries. An abdominal aortic ultrasound measures the size of the aorta, the major blood vessel that transports blood from the heart to the rest of the body (aorta). A venous ultrasound examines the circulation in the veins of the arms and legs, most commonly looking for blood clots. A lower extremity arterial evaluation (also known as ankle-brachial testing or pulse volume recording test) looks at the arterial blood flow to the lower body and legs. If an activity causes leg pain relieved by rest, this procedure may be ordered.

Geographical Analysis

North America region is expected to hold the largest market share in the global vascular imaging market

The presence of major players, reimbursement policies, rising stroke incidence, and prevalence of cardiovascular disorders are expected to drive growth in this region. According to the American Heart Association's 2019 heart disease and stroke statistics, an American has a stroke every 40 seconds, and approximately 795,000 Americans have a new or recurring stroke each year.

Moreover, Abbott Laboratories, a multinational American medical device and healthcare company, Abbott's OPTIS Imaging Systems, combines high-resolution OCT intravascular imaging and coronary physiology (RFR*/FFR) on a single platform to help guide PCI (Percutaneous coronary intervention) decisions. Hence, major key players in this region are expected to drive market growth.

Global Vascular Imaging Market- Segment Analysis

Based on type, the non-invasive segment is expected to dominate the market growth

A common imaging exam is non-invasive vascular imaging. It enables a doctor to assess the condition of blood vessels from the outside of the body. This entails employing several technologies, such as CT, MRI, ultrasound, vascular ultrasound. A contrast dye may be administered via a traditional IV (intravenous) line for CT and MRI exams. No catheters or other devices are inserted into the body because these studies are 'non-invasive.' These exams are performed in one of the hospital's radiology departments or a lab. A technologist typically performs the exam, and the results are interpreted and shared with a doctor by a radiologist. These minimally invasive imaging techniques are painless and relatively safe may eliminate the need for catheter-directed invasive procedures, allowing patients to leave the hospital immediately after the scan is completed.

Non-invasive vascular tests come in various forms, including a carotid ultrasound that measures arterial blood flow to the brain via the carotid arteries. An abdominal aortic ultrasound measures the size of the aorta, the major blood vessel that transports blood from the heart to the rest of the body (aorta). A venous ultrasound examines the circulation in the veins of the arms and legs, most commonly looking for blood clots. A lower extremity arterial evaluation (also known as ankle-brachial testing or pulse volume recording test) looks at the arterial blood flow to the lower body and legs. If an activity causes leg pain relieved by rest, this procedure may be ordered.

Geographical Analysis

North America region is expected to hold the largest market share in the global vascular imaging market

The presence of major players, reimbursement policies, rising stroke incidence, and prevalence of cardiovascular disorders are expected to drive growth in this region. According to the American Heart Association's 2019 heart disease and stroke statistics, an American has a stroke every 40 seconds, and approximately 795,000 Americans have a new or recurring stroke each year.

Moreover, Abbott Laboratories, a multinational American medical device and healthcare company, Abbott's OPTIS Imaging Systems, combines high-resolution OCT intravascular imaging and coronary physiology (RFR*/FFR) on a single platform to help guide PCI (Percutaneous coronary intervention) decisions. Hence, major key players in this region are expected to drive market growth.

Competitive Landscape

The global vascular imaging market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Hitachi Medical Corporation, Samsung Medison, Shimadzu Medical Systems, Hologic Inc., Abbott Laboratories, Fujifilm SonoSite, CorVascular Diagnostics

GE Healthcare

Overview: GE Healthcare is a subsidiary of General Electric, an American multinational conglomerate founded in New York and headquartered in Chicago, Illinois. The company was founded in 1994.

Product Portfolio: VesselIQ Xpress with Autobone gives easy-to-use tools for analyzing CT angiographic data, such as stenosis analysis, thrombus, pre and post-stent planning procedures, and directional vessel tortuosity visualization. These applications' display, measurement, and batch filming/archiving features will help maintain a more streamlined and productive workflow.

Why Purchase the Report?

Visualize the composition of the global vascular imaging market segmentation by type, by application, and end-user highlighting the key commercial assets and players.

Identify commercial opportunities in global vascular imaging market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global vascular imaging market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global vascular imaging market report would provide an access to an approx. 45+market data table, 40+figures and 190 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Vascular Imaging Market- By Type

Non-Invasive

Abdominal ultrasound

Angiography

Ankle-brachial index (ABI)

Captopril renal scan

Carotid duplex ultrasound

CT scan

Doppler ultrasound

Duplex ultrasound

MRA (magnetic resonance angiography)

MRI (magnetic resonance imaging)

Minimally Invasive

Catheter angiogram

CTA

Lymphoscintigraphy

Venogram

Intravascular ultrasound

Global Vascular Imaging Market-By Application

Diagnostic

Therapeutic

Global Vascular Imaging Market- By End User

Hospitals

Diagnostic Imaging Centers

Other

Global Vascular Imaging Market- By Region

North America

Europe

South America

Asia Pacific

Middle East and Africa

Table of Contents

1. Global Vascular Imaging Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Vascular Imaging Market- Market Definition and Overview

3. Global Vascular Imaging Market- Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Application
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet By Region

4. Global Vascular Imaging Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing demand for vascular imaging
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations associated with vascular imaging
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Vascular Imaging Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Global Vascular Imaging Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Vascular Imaging Market- By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.3. Market Attractiveness Index, By Type
    • 7.3.1. Non-Invasive
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      • 7.3.1.1.3. Abdominal ultrasound
      • 7.3.1.1.4. Angiography
      • 7.3.1.1.5. Ankle-brachial index (ABI)
      • 7.3.1.1.6. Captopril renal scan
      • 7.3.1.1.7. Carotid duplex ultrasound
      • 7.3.1.1.8. CT scan
      • 7.3.1.1.9. Doppler ultrasound
      • 7.3.1.1.10. Duplex ultrasound
      • 7.3.1.1.11. MRA (magnetic resonance angiography)
      • 7.3.1.1.12. MRI (magnetic resonance imaging)
    • 7.3.2. Minimally Invasive
      • 7.3.2.1. Catheer angiogram
      • 7.3.2.2. CT
      • 7.3.2.3. Lymoscintigraphy
      • 7.3.2.4. Venoam
      • 7.3.2.5. Intrascular ultrasound

8. Global Vascular Imaging Market-By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
  • 8.3. Market Attractiveness Index,By Application
    • 8.3.1. Diagnostic*
      • 8.3.1.1.1. Introduction
      • 8.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 8.3.2. Therapeutic

9. Global Vascular Imaging Market- By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.2.3. Diagnostic Imaging Centers
    • 9.2.4. Other

10. Global Vascular Imaging Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.5.1. U.S.
      • 10.2.5.2. Canada
      • 10.2.5.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.5.1. Brazil
      • 10.4.5.2. Argentina
      • 10.4.5.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Vascular Imaging Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Vascular Imaging Market- Company Profiles

  • 12.1. GE Healthcare*
      • 12.1.1.1. Company Overview
      • 12.1.1.2. Product Portfolio and Description
      • 12.1.1.3. Key Highlights
      • 12.1.1.4. Financial Overview
  • 12.2. Abbott Laboratories
  • 12.3. Siemens Healthineers
  • 12.4. Koninklijke Philips N.V.
  • 12.5. Hitachi Medical Corporation
  • 12.6. Samsung Medison
  • 12.7. Shimadzu Medical Systems
  • 12.8. Hologic Inc.
  • 12.9. Fujifilm SonoSite
  • 12.10. CorVascular Diagnostics

LIST NOT EXHAUSTIVE

13. Global Vascular Imaging Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us